A 60-day trial in India found that taking nicotinamide mononucleotide (NMN) at 600mg per day is the optimal dose for boosting the body’s nicotinamide adenine dinucleotide (NAD+) level and physical performance.
NMN, an anti-aging ingredient, has been disallowed by FDA because of its prior investigation as a drug. The determination, which came as something of a surprise given the ingredient’s market history, has raised questions of fairness and transparency.
Nicotinamide adenine dinucleotide (NAD+) loss is more significant in middle-aged men than women, a study funded by China dietary supplement giant BYHEALTH and national R&D institutions has found.
This round-up of new scientific findings will look at how low NAD+ level is associated with anaemia in women, Mitsubishi Life Sciences’ NMN clinical study findings, and the benefits of vitamin E for exercise recovery and PCOS.
Nicotinamide mononucleotide (NNM) supplementation is safe and practical strategy to boost NAD+levels, which plays a crucial role in cell function, among healthy subjects.
Supplements that claim to boost the body’s level of nicotinamide adenine dinucleotide (NAD+), namely nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR), are increasingly common in Asia’s dietary supplement market.
Entity Health has created a novel dietary supplement, in which the oxidised form of nicotinamide adenine dinucleotide, also known as NAD+, could be delivered in the form of sublingual wafers.
Next Miracle Nutrient is opening its first retail outlet in Hong Kong selling its nicotinamide mononucleotide (NMN) supplement, with the firm also hoping it will serve as an ‘experience centre’ to educate the public on NMN.
China’s consumers are increasingly aware of how nicotinamide adenine dinucleotide (NAD+) plays a role in health, and Chromadex believes this presents opportunities for its flagship product Tru Niagen.
Hong Kong-based start-up Supernine is planning to distribute its healthy ageing supplements and coffee products containing nicotinamide mononucleotide (NMN) into China and Singapore this year.
